Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Completed · Phase 3 · Has a placebo group

Conditions studied: Insomnia Disorder

In brief

Study to assess the long term safety and tolerability of daridorexant in adult and elderly subjects suffering from difficulties to sleep

Key facts

Study ID
NCT03679884
Run by
Idorsia Pharmaceuticals Ltd.
People needed
804
Starts
2018-10-09
Expected to finish
2021-02-22
Last updated by the study team
2022-03-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.